David Francis Carroll - 09 Dec 2022 Form 4 Insider Report for IVERIC bio, Inc.

Role
CFO
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for David Carroll
Issuer symbol
N/A
Transactions as of
09 Dec 2022
Net transactions value
-$189,606
Form type
4
Filing time
13 Dec 2022, 20:01:49 UTC
Previous filing
05 Apr 2022
Next filing
20 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $0 +10,000 +24% $0.000000 50,998 09 Dec 2022 Direct F1, F2
transaction ISEE Common Stock Sale $49,687 -2,405 -4.7% $20.66 48,593 12 Dec 2022 Direct F3, F4
transaction ISEE Common Stock Sale $32,746 -1,541 -3.2% $21.25 47,052 12 Dec 2022 Direct F3, F5
transaction ISEE Common Stock Options Exercise $0 +12,500 +27% $0.000000 59,552 12 Dec 2022 Direct F1
transaction ISEE Common Stock Sale $107,172 -4,932 -8.3% $21.73 54,620 13 Dec 2022 Direct F6, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -10,000 -50% $0.000000 10,000 09 Dec 2022 Common Stock 10,000 Direct F1, F8
transaction ISEE Restricted Stock Units Options Exercise $0 -12,500 -100% $0.000000* 0 12 Dec 2022 Common Stock 12,500 Direct F1, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 This total includes 832 shares acquired by the Reporting Person on September 15, 2022, under the Registrant's 2016 Employee Stock Purchase Plan that were not previously reported.
F3 Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 9, 2022.
F4 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $20.05 to $20.96 on December 12, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F5 The sale price of the Reporting Person's shares represents the price of all shares sold by a broker in multiple transactions effected on December 12, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees.
F6 Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 12, 2022.
F7 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $21.31 to $22.13 on December 13, 2022 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F8 On December 9, 2019, the Reporting Person was granted an awarded of 40,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.
F9 On December 12, 2018, the Reporting Person was granted 50,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.